Back to Search
FRANKIE HOLMES, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1336187897Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
G0728(TX)
Research & Publications (20)
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.
PMID 12123336·Ann Oncol·2002
3-trial
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
PMID 11821454·J Clin Oncol·2002
3-trial
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
PMID 19139988·Breast Cancer Res Treat·2009
8-other
Novel mRNA isoforms of the sodium channels Na(v)1.2, Na(v)1.3 and Na(v)1.7 encode predicted two-domain, truncated proteins.
PMID 18675520·Neuroscience·2008
7-preclinical
William Henry, Duke of Gloucester (1689-1700), son of Queen Anne (1665-1714), could have ruled Great Britain.
PMID 18463064·J Med Biogr·2008
8-other
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
PMID 19073509·Clin Breast Cancer·2008
4-observational
Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour.
PMID 18410510·J Neurochem·2008
7-preclinical
Galanin acts as a trophic factor to the central and peripheral nervous systems.
PMID 18500646·Cell Mol Life Sci·2008
6-review
The sodium channel Nav1.5a is the predominant isoform expressed in adult mouse dorsal root ganglia and exhibits distinct inactivation properties from the full-length Nav1.5 channel.
PMID 17433712·Mol Cell Neurosci·2007
7-preclinical
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
PMID 17947724·J Clin Oncol·2007
4-observational
Characterization of an enhancer region of the galanin gene that directs expression to the dorsal root ganglion and confers responsiveness to axotomy.
PMID 17567818·J Neurosci·2007
7-preclinical
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
PMID 17329190·Lancet Oncol·2007
8-other
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
PMID 17009032·Cancer Chemother Pharmacol·2007
3-trial
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
PMID 17135639·J Clin Oncol·2006
3-trial
Reminiscences of an early dental practitioner in western Oklahoma. 1941.
PMID 16910245·J Okla Dent Assoc·2006
8-other
Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour.
PMID 17076662·J Neurochem·2006
7-preclinical
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
PMID 15748464·Clin Breast Cancer·2005
3-trial
Use of genetically engineered transgenic mice to investigate the role of galanin in the peripheral nervous system after injury.
PMID 15944011·Neuropeptides·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 925 GESSNER RD, SUITE 550
HOUSTON, TX 77024 - Phone
- (713) 467-1722
Quick Facts
- NPI
- 1336187897
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile